Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities

Metabolism: Clinical and Experimental

Volumn 64, Issue 9, 2015, Pages 1086-1095

  Akinci, Baris ^a   Koseoglu, Fatos Dilan ^b   Onay, Huseyin ^c   Yavuz, Sevgi ^d   Altay, Canan ^a   Simsir, Ilgin Yildirim ^c   Ozisik, Secil ^a   Demir, Leyla ^e   Korkut, Meltem ^f   Yilmaz, Nusret ^g   Ozen, Samim ^c   Akinci, Gulcin ^h   Atik, Tahir ^c   Calan, Mehmet ^a   Secil, Mustafa ^a   Comlekci, Abdurrahman ^a   Demir, Tevfik ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Tepecik Training Hospital   (Turkey)

^c EGE UNIVERSITY   (Turkey)

^d Infectious Disease Department   (Turkey)

^e ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^f YEDITEPE UNIVERSITY   (Turkey)

^g AKDENIZ UNIVERSITY   (Turkey)

^h DR BEHÇET UZ CHILDREN'S HOSPITAL   (Turkey)

Author keywords

APL; Diabetes; Hepatic steatosis; Hypertriglyceridemia; Insulin resistance

Indexed keywords

ADIPONECTIN; ANTINUCLEAR ANTIBODY; C PEPTIDE; CALCITRIOL; CALCIUM; CARDIOLIPIN ANTIBODY; FENOFIBRATE; GEMFIBROZIL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; METFORMIN PLUS PIOGLITAZONE; OMEGA 3 FATTY ACID; PIOGLITAZONE; RAMIPRIL; REPAGLINIDE; TRIACYLGLYCEROL;

ACANTHOSIS NIGRICANS; ACQUIRED PARTIAL LIPODYSTROPHY; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONGENITAL GENERALIZED LIPODYSTROPHY; CONTROLLED STUDY; END STAGE RENAL DISEASE; FATTY LIVER; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMODIALYSIS; HEPATOMEGALY; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPODYSTROPHY; LIVER BIOPSY; MALE; METABOLIC DISORDER; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; TEST MEAL; TRIACYLGLYCEROL BLOOD LEVEL; TURKISH CITIZEN; WHOLE BODY MRI; YOUNG ADULT; AGED; BLOOD; COMPLICATION; DIABETES COMPLICATIONS; METABOLIC DISEASES; REGISTER; RISK; TURKEY;

ADIPONECTIN; ADOLESCENT; ADULT; AGED; COHORT STUDIES; DIABETES COMPLICATIONS; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPTIN; LIPODYSTROPHY; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC DISEASES; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RISK; TURKEY; YOUNG ADULT;

EID: 84939571690     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.06.004     Document Type: Article

References (27)

1. A. Garg Clinical review#: lipodystrophies: genetic and acquired body fat disorders J Clin Endocrinol Metab 96 2011 3313 3325
2. A. Garg Lipodystrophies Am J Med 108 2000 143 152
3. A. Misra, A. Peethambaram, and A. Garg Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature Medicine (Baltimore) 83 2004 18 34
4. A. Garg Acquired and inherited lipodystrophies N Engl J Med 350 2004 1220 1234
5. V.A. Cortes, and M. Fernandez-Galilea Lipodystrophies: adipose tissue disorders with severe metabolic implications J Physiol Biochem 2015 10.1007/s13105-015-0404-1 [Epub ahead of print]
6. A. Garg, and A. Misra Lipodystrophies: rare disorders causing metabolic syndrome Endocrinol Metab Clin North Am 33 2004 305 331
7. S. Yavuz, and T.O. Acarturk Acquired partial lipodystrophy with C3 hypocomplementemia and antiphospholipid and anticardiolipin antibodies Pediatr Dermatol 27 2010 504 508
8. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
9. R.H. Eckel, J.M. Jakicic, J.D. Ard, J.M. de Jesus, N. Houston Miller, V.S. Hubbard, and et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 2014 S76 S99
10. Standards of medical care in diabetes - 2014 Diabetes Care 37 Suppl. 1 2014 S14 S80
11. I. Satman, B. Omer, Y. Tutuncu, S. Kalaca, S. Gedik, N. Dinccag, and et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults Eur J Epidemiol 28 2013 169 180
12. A.G. Jones, and A.T. Hattersley The clinical utility of C-peptide measurement in the care of patients with diabetes Diabet Med 30 2013 803 817
13. D.B. Savage Mouse models of inherited lipodystrophy Dis Model Mech 2 2009 554 562
14. W.A. Haque, I. Shimomura, Y. Matsuzawa, and A. Garg Serum adiponectin and leptin levels in patients with lipodystrophies J Clin Endocrinol Metab 87 2002 2395
15. H.K. Park, and R.S. Ahima Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism Metabolism 64 2015 24 34
16. D.B. Savage, K.F. Petersen, and G.I. Shulman Disordered lipid metabolism and the pathogenesis of insulin resistance Physiol Rev 87 2007 507 520
17. K.F. Petersen, and G.I. Shulman Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus Am J Cardiol 90 2002 11G 18G
18. G.I. Shulman Cellular mechanisms of insulin resistance J Clin Invest 106 2000 171 176
19. M.A. Tsoukas, O.M. Farr, and C.S. Mantzoros Leptin in congenital and HIV-associated lipodystrophy Metabolism 64 2015 47 59
20. J.L. Chan, and E.A. Oral Clinical classification and treatment of congenital and acquired lipodystrophy Endocr Pract 16 2010 310 323
21. S. Bindlish, L.S. Presswala, and F. Schwartz Lipodystrophy: syndrome of severe insulin resistance Postgrad Med 1-6 2015
22. K. Chou, and C.M. Perry Metreleptin: first global approval Drugs 73 2013 989 997
23. G. Paz-Filho, C.A. Mastronardi, and J. Licinio Leptin treatment: facts and expectations Metabolism 64 2015 146 156
24. S.A. Polyzos, J. Kountouras, and C.S. Mantzoros Leptin in nonalcoholic fatty liver disease: a narrative review Metabolism 64 2015 60 78
25. J.P. Foo, and C.S. Mantzoros Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: a need for more mechanistic studies and large, randomized, placebo-controlled trials Metabolism 61 2012 1331 1336
26. J.Y. Park, E.D. Javor, E.K. Cochran, A.M. DePaoli, and P. Gorden Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy Metabolism 56 2007 508 516
27. M.L. Reitman, E. Arioglu, O. Gavrilova, and S.I. Taylor Lipoatrophy revisited Trends Endocrinol Metab 11 2000 410 416